查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086070

微創青光眼手術醫療設備市場：2026-2032年全球市場預測（依器械類型、手術部位、適應症、手術方法、手術類型、器械分類、支付方式、病患類型、易用性、最終用戶和通路分類）

Minimally Invasive Glaucoma Surgery Devices Market by Device Type, Surgical Site, Indication, Surgical Approach, Procedure Type, Device Class, Payment Method, Patient Type, Usability, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，微創青光眼手術醫療設備市場將成長至 9.448 億美元，複合年成長率為 5.82%。

主要市場統計數據
基準年 2025 6.3551億美元
預計年份：2026年 6.7186億美元
預測年份 2032 9.448億美元
複合年成長率 (%) 5.82%

微創青光眼醫療設備正在革新青光眼的治療方式，它提供了一種介於眼藥水、雷射治療和傳統切除術及引流管植入術之間的微創手術選擇。臨床需求龐大。同行評審的流行病學研究表明，2020年全球約有7600萬40至80歲的人群患有青光眼，預計到2040年，這一數字將達到1.118億。

微創青光眼手術（MIGS）的廣泛應用主要受人口老化、白內障手術增多以及對既能降低眼壓和用藥負擔又能確保安全性的手術的需求所驅動。臨床應用最顯著的地區是那些眼科醫生能夠獲得醫保覆蓋的醫療設備、現代化的門診手術基礎設施、光學同調斷層掃描（OCT）、使用房角鏡進行的手術培訓以及青光眼長期監測的地區。

一項變革性的改變將重塑微創胃腸道手術（MIGS）的應用格局。

微創青光眼手術（MIGS）的發展趨勢正從最初僅與白內障手術合併使用，轉向更廣泛的青光眼治療。小梁微旁路支架、管狀成形系統、角膜下切口裝置、結膜下植入和脈絡膜上腔入路等技術在耐用性、安全性、植入便利性和與眼科手術流程的契合度方面展開競爭。

人工智慧對青光眼手術路徑的累積影響

人工智慧 (AI) 的影響已超越設備設計，滲透到青光眼診療的整個流程，並累積累積。利用 AI 分析光學相干斷層掃描 (OCT)、眼底成像、視野檢查和電子健康記錄，可輔助進行風險分層、檢測疾病進展、確定轉診優先順序，並篩選可能受益於微創青光眼手術的患者。

全球MIGS市場區域趨勢

北美仍然是微創青光眼醫療設備商業化的領先地區，這得益於其獲得FDA已通過核准的技術、大量的白內障手術、青光眼專科醫生網路以及美國和加拿大完善的門診手術中心。歐洲受益於其主要醫療保健系統內先進的眼科基礎設施，但醫療設備法規（MDR）對臨床證據、上市後監測和技術文件提出了更嚴格的要求。

群體層面的需求趨勢與政策趨勢

歐盟的醫療設備法規比統一法規更為嚴格，這有利於擁有可靠臨床證據、品管系統和上市後監測的製造商。在七國集團（G7）市場，眼科支出高昂，外科醫師培訓計畫眾多，白內障手術流程成熟，且早期採用數據驅動的青光眼治療方法，因此，證據的品質及其與保險報銷體系的契合度是微創青光眼手術醫療設備廣泛應用的關鍵因素。

國家層級的採用趨勢

美國憑藉其FDA核准流程、與聯邦醫療保險（Medicare）掛鉤的報銷體系、較高的青光眼診斷率以及在門診手術中心的廣泛應用，在微創青光眼手術醫療設備市場佔據著至關重要的地位。在加拿大，實證醫學的應用正透過省級醫療保健系統和眼科醫生網路逐步推進。同時，在墨西哥和巴西，儘管公共青光眼醫療服務的可近性仍然存在差異，但私營部門的應用正在加速發展。

為行業領導者提供的實用建議

產業領導者應優先考慮有關降低眼壓、減少藥物治療、不利事件、再治療率、視野穩定性、內皮細胞安全性和生活品質 (QOL) 等結果的嚴格比較證據。隨著支付者、監管機構和外科醫生越來越要求在短期主要臨床試驗之外獲得持續的價值，真實世界註冊研究和長期追蹤至關重要。

實證調查方法

本執行摘要基於對同行評審的青光眼流行病學研究的多方面二次調查、來自世界衛生組織 (WHO) 等公共衛生組織的資訊、包括 FDA 和歐洲當局在內的監管機構的資訊、眼科指南、保險報銷資訊、臨床文獻和公開的政策文件。

結論：微創手術正在朝著數據驅動的早期治療方向發展。

隨著臨床醫生尋求更安全、更早、更具臨床意義的開放性青光眼和白內障相關手術治療方案，微創青光眼手術（MIGS）醫療設備在現代青光眼治療中發揮著至關重要的作用。其廣泛應用主要受以下因素驅動：全球範圍內青光眼負擔沉重、人口老化、影像診斷的日益普及以及減少長期依賴眼藥水的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：微創青光眼手術醫療設備市場：依器材類型分類

  • 消融工具
  • 導管
  • 基於管腔的分流器
    • 固定內徑
    • 流量控制類型
  • 支架/擴張器
  • 支架

第8章：微創青光眼手術醫療設備市場：依手術部位分類

  • 睫狀體
  • 施萊姆管
  • 結膜下間隙
  • 脈絡膜上腔
  • 小梁網

第9章：微創青光眼手術醫療設備市場：依適應症分類

  • 隅角閉鎖性青光眼
  • 先天性青光眼
  • 原發性開放性青光眼
  • 續發性青光眼

第10章：微創青光眼手術醫療設備市場：依手術方法分類

  • Ab Externo
  • Ab Interno

第11章：微創青光眼手術醫療設備市場：依手術類型分類

  • 與白內障手術合併使用
  • 單次手術

第12章：微創青光眼手術醫療設備市場：依植入材料分類

  • 金屬
    • 鎳鈦諾
    • 鈦
  • 聚合物
    • 明膠
    • 聚醚碸
    • 聚醯亞胺
    • 矽酮

第13章：微創青光眼手術醫療設備市場：依器材分類

  • 嵌入式
  • 非植入式

第14章：微創青光眼手術醫療設備市場：依支付方式分類

  • 贖回基礎
  • 自費

第15章：微創青光眼手術醫療設備市場：依病患類型分類

  • 兒童
  • 成人

第16章：微創青光眼手術醫療設備市場：依易用性分類

  • 可重複使用的
  • 拋棄式的

第17章：微創青光眼手術醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 眼科診所
  • 專科眼科醫院

第18章：微創青光眼手術醫療設備市場：依分銷管道分類

  • 離線
  • 線上

第19章：微創青光眼手術醫療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第20章：微創青光眼手術醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第21章：微創青光眼手術醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第22章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第23章：公司簡介

  • AbbVie Inc.
  • Alcon Vision LLC
  • Avisi Technologies, Inc.
  • Bausch+Lomb Corp.
  • BVI Medical, Inc.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Corza Ophthalmology Products, Inc.
  • Glaukos Corporation
  • Haag-Streit Group by Metall Zug AG
  • Iridex Corporation
  • iSTAR Medical
  • Johnson & Johnson Services, Inc.
  • Lantrek, Inc.
  • LIQID Medical（Pty）Ltd.
  • Lumenis Be Ltd.
  • Lumibird Medical
  • New World Medical, Inc.
  • Nova Eye Medical Limited
  • Oertli Instrumente AG
  • Rheon Medical SA
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-036C5CF3A869

The Minimally Invasive Glaucoma Surgery Devices Market is projected to grow by USD 944.80 million at a CAGR of 5.82% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 635.51 million
Estimated Year [2026] USD 671.86 million
Forecast Year [2032] USD 944.80 million
CAGR (%) 5.82%

Minimally invasive glaucoma surgery devices are reshaping glaucoma management by offering a lower-trauma surgical option between topical medication, laser therapy, and conventional trabeculectomy or tube shunt surgery. The clinical need is substantial: peer-reviewed epidemiology estimates that approximately 76 million people aged 40 to 80 had glaucoma in 2020, with prevalence projected to reach 111.8 million by 2040.

MIGS adoption is supported by aging populations, rising cataract surgery volumes, and demand for procedures that can reduce intraocular pressure and medication burden while preserving safety. Growth in clinical use is strongest where ophthalmologists have access to reimbursed devices, modern ambulatory surgery infrastructure, optical coherence tomography, gonioscopy-based surgical training, and longitudinal glaucoma monitoring.

Transformative Shifts Reshaping MIGS Adoption

The MIGS landscape is moving from a cataract-combination niche toward broader procedural glaucoma care. Trabecular micro-bypass stents, canaloplasty systems, goniotomy devices, subconjunctival implants, and suprachoroidal approaches are competing on durability, safety profile, ease of implantation, and fit within ophthalmic surgery workflows.

Key shifts include earlier intervention in mild-to-moderate open-angle glaucoma, greater attention to medication adherence challenges, and stronger post-market evidence requirements. Regulatory scrutiny, surgeon training, reimbursement coding, and comparative outcomes versus selective laser trabeculoplasty and conventional filtration surgery are now central to commercial success in the minimally invasive glaucoma surgery devices landscape.

Cumulative Impact of AI on Glaucoma Surgery Pathways

Artificial intelligence is increasingly cumulative across the glaucoma care pathway rather than limited to device design. AI-enabled analysis of OCT, fundus imaging, visual fields, and electronic health records can support risk stratification, progression detection, referral prioritization, and selection of patients who may benefit from minimally invasive glaucoma surgery.

AI also improves operational efficiency by helping clinics manage follow-up intervals and identify nonadherence risk. However, adoption depends on validated datasets, explainability, cybersecurity, and regulatory compliance. In MIGS, the near-term impact is strongest in diagnostics, surgical planning, outcomes tracking, real-world evidence generation, and post-procedure monitoring of intraocular pressure control.

Regional Dynamics Across Global MIGS Markets

North America remains a leading region for minimally invasive glaucoma surgery device commercialization due to FDA-cleared technologies, high cataract procedure volumes, glaucoma subspecialty networks, and established ambulatory surgery centers in the United States and Canada. Europe benefits from advanced ophthalmology infrastructure across major health systems, while the Medical Device Regulation has increased requirements for clinical evidence, post-market surveillance, and technical documentation.

Asia-Pacific offers major long-term clinical potential because glaucoma prevalence rises with aging, urbanization, diabetes comorbidity, and expanding eye-care access in China, India, Japan, South Korea, and Australia. Japan, Australia, and South Korea support advanced ophthalmic procedures through specialist capacity and structured health systems, while China and India combine large glaucoma populations with expanding private and public eye-care networks.

Latin America, the Middle East, and Africa show demand linked to unmet glaucoma diagnosis and treatment needs, but affordability, specialist density, surgical training access, and reimbursement variability shape adoption speed. Brazil and Mexico anchor Latin American uptake through private ophthalmology centers; GCC countries in the Middle East benefit from investment in tertiary hospitals; and Africa's adoption is constrained by late diagnosis, limited glaucoma specialist availability, and uneven access to surgical infrastructure.

Group-Level Demand Patterns and Policy Signals

The European Union is defined by harmonized but more rigorous device regulation, favoring manufacturers with strong clinical evidence, quality systems, and post-market surveillance. G7 markets concentrate premium ophthalmic spending, surgeon training capacity, established cataract surgery workflows, and early adoption of data-driven glaucoma care, making evidence quality and reimbursement alignment decisive for minimally invasive glaucoma surgery device uptake.

BRICS countries represent large patient pools and expanding private ophthalmology networks, especially in China, India, and Brazil, while Russia is more affected by procurement limitations and geopolitical constraints. ASEAN markets are heterogeneous, with Singapore, Thailand, and Malaysia supporting advanced procedures sooner than lower-income systems, where affordability and specialist availability remain key barriers.

GCC countries benefit from specialty hospital investment, medical tourism strategies, and public-sector modernization programs that can support premium ophthalmic technologies when clinical value is demonstrated. NATO countries overlap with many high-income markets where procurement standards, supply-chain resilience, cybersecurity, and regulatory compliance are increasingly relevant for AI-enabled glaucoma diagnostics, surgical planning platforms, and connected post-market data systems.

Country-Level Adoption Signals

The United States is a pivotal minimally invasive glaucoma surgery device market because of FDA pathways, Medicare-linked reimbursement, high glaucoma diagnosis volumes, and extensive ambulatory surgery center use. Canada follows evidence-based adoption through provincial health systems and specialist ophthalmology networks, while Mexico and Brazil show private-sector momentum alongside persistent access gaps in public glaucoma care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize clinical value, cost-effectiveness, safety documentation, and compliance with EU or domestic device rules. Germany and France have strong specialist infrastructure, the United Kingdom places significant weight on health technology assessment and guideline alignment, Italy and Spain combine advanced ophthalmology centers with regional reimbursement differences, and Russia remains influenced by procurement constraints, import dynamics, and geopolitical pressures.

China and India offer scale because of large aging populations and expanding eye-care infrastructure, though reimbursement, surgeon training, and affordability shape device selection. Japan prioritizes quality, safety, and clinical evidence, Australia supports specialist uptake through advanced ophthalmology networks, and South Korea combines high procedural sophistication with strong medical technology capabilities, creating favorable conditions for glaucoma imaging, surgical innovation, and post-procedure monitoring.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize rigorous comparative evidence, including intraocular pressure reduction, medication reduction, adverse events, retreatment rates, visual field stability, endothelial cell safety, and quality-of-life outcomes. Real-world registries and long-term follow-up are essential because payers, regulators, and surgeons increasingly demand durable value beyond short pivotal trials.

Commercial strategies should align device design with surgeon learning curves, procedure time, reimbursement codes, cataract workflow integration, and glaucoma severity segmentation. Organizations should also invest in AI-ready data infrastructure, physician education, market-access dossiers, health economic evidence, and region-specific pricing models for high-growth but cost-sensitive markets.

Evidence-Based Research Methodology

This executive summary is grounded in triangulated secondary research from peer-reviewed glaucoma epidemiology, public health agencies such as the World Health Organization, regulatory sources including the FDA and European authorities, ophthalmology guidelines, reimbursement information, clinical literature, and publicly available policy documents.

The analysis evaluates device categories, clinical indications, regional healthcare infrastructure, demographic demand, competitive positioning, regulatory expectations, and policy signals. Emphasis is placed on verified trends rather than speculative market claims, with qualitative interpretation anchored to documented disease burden, regulatory pathways, clinical evidence requirements, and observed adoption drivers.

Conclusion: MIGS Moves Toward Earlier, Data-Guided Care

Minimally invasive glaucoma surgery devices are becoming an important part of modern glaucoma care as clinicians seek safer, earlier, and more workflow-compatible interventions for open-angle glaucoma and cataract-associated surgical pathways. Adoption is supported by a large global glaucoma burden, aging demographics, increased diagnostic imaging use, and the need to reduce long-term dependence on topical medications.

Future leadership will depend on evidence quality, reimbursement alignment, surgeon confidence, regulatory readiness, and integration with AI-enabled diagnostics and outcomes monitoring. Device developers and healthcare stakeholders that combine clinical durability, accessible training, and region-specific market strategies will be best positioned in the evolving minimally invasive glaucoma surgery device ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Minimally Invasive Glaucoma Surgery Devices Market, by Device Type

  • 7.1. Ablation Tools
  • 7.2. Catheter
  • 7.3. Lumen-Based Shunts
    • 7.3.1. Fixed-Lumen
    • 7.3.2. Flow-Controlled
  • 7.4. Scaffold/Expander
  • 7.5. Stents

8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Site

  • 8.1. Ciliary Body
  • 8.2. Schlemm's Canal
  • 8.3. Subconjunctival Space
  • 8.4. Suprachoroidal Space
  • 8.5. Trabecular Meshwork

9. Minimally Invasive Glaucoma Surgery Devices Market, by Indication

  • 9.1. Angle-Closure Glaucoma
  • 9.2. Congenital Glaucoma
  • 9.3. Primary Open Angle Glaucoma
  • 9.4. Secondary Glaucoma

10. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Approach

  • 10.1. Ab Externo
  • 10.2. Ab Interno

11. Minimally Invasive Glaucoma Surgery Devices Market, by Procedure Type

  • 11.1. Combined With Cataract Surgery
  • 11.2. Standalone Procedure

12. Minimally Invasive Glaucoma Surgery Devices Market, by Implant Material

  • 12.1. Metals
    • 12.1.1. Nitinol
    • 12.1.2. Titanium
  • 12.2. Polymers
    • 12.2.1. Gelatin
    • 12.2.2. Polyethersulfone
    • 12.2.3. Polyimide
    • 12.2.4. Silicone

13. Minimally Invasive Glaucoma Surgery Devices Market, by Device Class

  • 13.1. Implantable
  • 13.2. Non-implantable

14. Minimally Invasive Glaucoma Surgery Devices Market, by Payment Method

  • 14.1. Reimbursement-Based
  • 14.2. Self-Pay

15. Minimally Invasive Glaucoma Surgery Devices Market, by Patient Type

  • 15.1. Pediatric
  • 15.2. Adult

16. Minimally Invasive Glaucoma Surgery Devices Market, by Usability

  • 16.1. Reusable
  • 16.2. Disposable

17. Minimally Invasive Glaucoma Surgery Devices Market, by End User

  • 17.1. Ambulatory Surgery Centers
  • 17.2. Ophthalmic Clinics
  • 17.3. Specialty Eye Hospitals

18. Minimally Invasive Glaucoma Surgery Devices Market, by Distribution Channel

  • 18.1. Offline
  • 18.2. Online

19. Minimally Invasive Glaucoma Surgery Devices Market, by Region

  • 19.1. Asia-Pacific
  • 19.2. North America
  • 19.3. Latin America
  • 19.4. Europe
  • 19.5. Middle East
  • 19.6. Africa

20. Minimally Invasive Glaucoma Surgery Devices Market, by Group

  • 20.1. ASEAN
  • 20.2. GCC
  • 20.3. European Union
  • 20.4. BRICS
  • 20.5. G7
  • 20.6. NATO

21. Minimally Invasive Glaucoma Surgery Devices Market, by Country

  • 21.1. United States
  • 21.2. Canada
  • 21.3. Mexico
  • 21.4. Brazil
  • 21.5. United Kingdom
  • 21.6. Germany
  • 21.7. France
  • 21.8. Russia
  • 21.9. Italy
  • 21.10. Spain
  • 21.11. China
  • 21.12. India
  • 21.13. Japan
  • 21.14. Australia
  • 21.15. South Korea

22. Competitive Landscape

  • 22.1. Market Concentration Analysis, 2025
    • 22.1.1. Concentration Ratio (CR)
    • 22.1.2. Herfindahl Hirschman Index (HHI)
  • 22.2. Recent Developments & Impact Analysis, 2025
  • 22.3. Product Portfolio Analysis, 2025
  • 22.4. Benchmarking Analysis, 2025

23. Company Profiles

  • 23.1. AbbVie Inc.
  • 23.2. Alcon Vision LLC
  • 23.3. Avisi Technologies, Inc.
  • 23.4. Bausch + Lomb Corp.
  • 23.5. BVI Medical, Inc.
  • 23.6. Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • 23.7. Corza Ophthalmology Products, Inc.
  • 23.8. Glaukos Corporation
  • 23.9. Haag-Streit Group by Metall Zug AG
  • 23.10. Iridex Corporation
  • 23.11. iSTAR Medical
  • 23.12. Johnson & Johnson Services, Inc.
  • 23.13. Lantrek, Inc.
  • 23.14. LIQID Medical (Pty) Ltd.
  • 23.15. Lumenis Be Ltd.
  • 23.16. Lumibird Medical
  • 23.17. New World Medical, Inc.
  • 23.18. Nova Eye Medical Limited
  • 23.19. Oertli Instrumente AG
  • 23.20. Rheon Medical SA
  • 23.21. Santen Pharmaceutical Co., Ltd.
  • 23.22. Sight Sciences, Inc.
  • 23.23. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 31. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 33. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 34. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 35. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 36. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 37. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ABLATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABLATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABLATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FIXED-LUMEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FIXED-LUMEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FIXED-LUMEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CILIARY BODY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CILIARY BODY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CILIARY BODY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SCHLEMM'S CANAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SCHLEMM'S CANAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SCHLEMM'S CANAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AB EXTERNO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AB EXTERNO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AB EXTERNO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AB INTERNO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AB INTERNO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AB INTERNO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL METALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL METALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NITINOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POLYETHERSULFONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POLYETHERSULFONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POLYETHERSULFONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POLYIMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POLYIMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POLYIMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SILICONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMPLANTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IMPLANTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMPLANTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SELF-PAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SELF-PAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SELF-PAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL REUSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL REUSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL REUSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DISPOSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DISPOSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 256. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 257. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 259. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 263. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 305. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 307. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 308. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 309. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 311. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 313. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 318. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET